Welcome to Our Knowledge Hub

A coalition of both public and exclusive information regarding the development of our novel CD8 ImmunoPET imaging agent, RPT, and more.

Join today to stay up to date on all things ImaginAb.

Notice: our Knowledge Hub is intended for Pharmaceutical and Biotechnology companies who are interested in or developing clinical trials. Your request to join will be reviewed by a team member shortly.

Already have an account?

Log In

Register for full access to the Knowledge Hub

Passwords must be at least 8 characters long and must contain at least one uppercase letter and one number.
  • I am employed by a Pharmaceutical, Biotechnology or Life Science company;
  • I am accessing the Knowledge Hub to evaluate Zirconium Zr 89 Crefmirlimab Berdoxam (CD8+ ImmunoPET) for use in clinical trial development programs of therapeutic products;
  • I will not use or disclose any information from the Knowledge Hub for any other purpose, including to develop competitive technology toZirconium Zr 89 Crefmirlimab Berdoxam (CD8+ ImmunoPET);
  • The information on the Knowledge Hub is ImaginAb’s confidential and proprietary information; and
  • Zirconium Zr 89 Crefmirlimab Berdoxam (CD8+ ImmunoPET) has not yet received market authorization from any health regulatory authority and remains an investigational technology.